Shares of Camtek Ltd. dropped sharply to $131.54 on Tuesday, surrendering 7.3% in a single session and extending a brutal slide that has erased roughly $14 per share — or nearly 20% — from the stock's recent peak near $163 on June 30. The catalyst on the way up was clear: when the company announced its $105 million AI-focused orders on June 2, CAMT surged nearly 15% in one day. Now the pendulum is swinging the other way, with no new negative headline in sight.
The Rally That Set Up the Fall. Camtek's June surge was driven by a $55 million multi-system order from a major chip-packaging contractor and $50 million in orders for its advanced inspection equipment from a leading memory manufacturer.
All of those systems are slated for delivery in 2027 — meaning the revenue won't show up for over a year. Investors who bought the announcement are now locking in gains as the NASDAQ drops 0.70% and semiconductor names broadly weaken.
The Valuation Still Looks Stretched. The stock trades around 50 times this year's earnings estimates, which means it could fall further on any hiccups in the growth story.
With a market cap of roughly $6.65 billion against trailing revenue of about $499 million , the premium baked into CAMT assumes a sustained AI-inspection boom — and leaves little room for execution stumbles.
Strong Backlog, But Customer Concentration Is a Risk. Earlier order wins at packaging contractors and chipmakers deepen Camtek's footprint in critical AI packaging flows, but the company remains heavily dependent on a concentrated set of high-performance computing and memory customers.
Q1 2026 revenue came in at $121.7 million, with guidance of $129–$131 million for Q2 and management projecting second-half growth exceeding 25%. Hitting that target is now the stock's make-or-break moment.
Wall Street Still Believes — For Now. Analysts maintain a Strong Buy consensus with a median price target of $187.50, supported by 7 Buy and 5 Hold ratings. That implies roughly 43% upside from today's beaten-down price. But earnings estimates have not moved higher in the last 30 days, and stocks rarely keep climbing without upward revisions.
The bottom line: Camtek's order book validates its role as a critical supplier for AI chipmaking. But with revenue from the headline orders still a year away and the stock priced for perfection, today's selloff is a reminder that even the best AI stories need quarterly proof points to sustain their premiums.